Key Factor Supporting Global Fertility Treatments Market Development in 2025: Rising IVF-Assisted Pregnancies Fueling Growth in Fertility Treatments Market

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Fertility Treatments Market Size By 2025?
The market encompassing fertility treatments has experienced robust expansion throughout the preceding years, projected to transition from its 2024 valuation of $18.09 billion to $19.52 billion in 2025, reflecting a compound annual growth rate of 7.9% across this span; this historical upward trajectory is traceable to a confluence of factors including the rising incidence of infertility, breakthroughs in the field of reproductive medicine, expanding healthcare provisions, heightened public understanding, and a diminishing social stigma surrounding these procedures.

How Big Is the Fertility Treatments Market Size Expected to Grow by 2029?
Projections indicate a robust expansion for the fertility treatments market in the coming years, anticipating it will reach a value of $27.42 billion by 2029, driven by an annual growth rate compounded at 8.9%. This upward trajectory throughout the projection span stems from factors such as individuals postponing parenthood, wider accessibility of reproductive healthcare offerings, progress in related technologies, and improved availability of services addressing infertility. Key developments set to shape this market over the forecast term encompass innovations in in vitro fertilization (IVF) procedures, the increasing adoption of single embryo transfer (SET) practices, the integration of telehealth and remote consultations, and the growing trend of fertility preservation options for individuals undergoing cancer treatment.

View the full report here:
https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report

Which Key Market Drivers Powering Fertility Treatments Market Expansion and Growth?
Anticipated expansion in pregnancies achieved through in vitro fertilization procedures is projected to act as a catalyst for the advancement of the fertility treatments sector in the coming period. These pregnancies, resulting from fertilization of an egg with sperm outside the body, often in a controlled laboratory environment, are becoming more frequent due to escalating infertility statistics, technological progress in reproductive science, and evolving social patterns like postponing starting a family and modifications in domestic arrangements. Supportive fertility interventions, encompassing hormonal regulation and oocyte retrieval processes, bolster IVF outcomes by optimizing egg yield, refining embryo viability, and substantially elevating the probability of successful conception and uterine embedding. To illustrate this trend, data provided by the American Society for Reproductive Medicine, a US non-profit entity, indicated that in the United States during 2022, approximately 91,771 infants were delivered following IVF, making up 2.5% of the total births for that year, accompanied by a notable uptick in IVF cycles executed, reaching 389,993, which represents a 6% year-over-year climb; consequently, the proliferation of IVF-dependent births is directly fueling the progression of the market for fertility therapies.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2811&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Fertility Treatments Market?
A significant movement within the fertility treatments sector involves pioneering novel methodologies that leverage the body's inherent capabilities for addressing infertility. INVOcell, presented as an alternative to traditional IVF, capitalizes on the female body to foster conception, thereby circumventing the necessity for a laboratory-based incubator. This INVOcell apparatus, housing both ova and sperm, is situated internally within the vaginal space, which ensures the crucial maintenance of natural parameters such as environmental stability, optimal pH, and suitable gas composition necessary for successful fertilization. Manufactured by INVO Bioscience in Medford, Massachusetts, the INVOcell procedure typically has an associated expense near $6,800 when encompassing pharmaceuticals. Despite observations indicating IVF yielded a greater quantity of viable embryos, actual live birth rates demonstrate parity between the two methods. Data published in the journal of assisted reproduction and genetics indicates that out of twenty women undergoing IVF, twelve achieved live births resulting in fifteen infants (inclusive of three instances of twins), whereas in the INVOcell cohort, eleven of twenty women delivered sixteen babies (incorporating five sets of twins).

What Are the Emerging Segments in the Fertility Treatments Market?
The fertility treatmentsmarket covered in this report is segmented -

1) By Product: Reagents; Equipment
2) By Patient Type: Female; Male
3) By End-User: Fertility Clinics; Hospitals; Surgical Centers; Clinical Research Institutes

Subsegments:
1) By Reagents: Ovulation Stimulation Reagents; Hormonal Reagents; Sperm Separation Reagents; Cryopreservation Reagents; Insemination Reagents
2) By Equipment: In Vitro Fertilization (IVF) Equipment; Fertility Monitors; Sperm Analysis Equipment; Embryo Culture Media Equipment; Cryopreservation Equipment; Ultrasound Equipment For Fertility; Artificial Insemination (AI) Equipment

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2811&type=smp

Who Are the Global Leaders in the Fertility Treatments Market?
Major companies operating in the fertility treatments market include Apollo Hospitals Enterprise Ltd., Care Fertility Group Limited, Genea Limited, Johns Hopkins Health System Corp., Medicover AB, Monash IVF Group, Progyny Inc., Vitrolife AB, Carolinas Fertility Institute PLLC, OvaScience Inc., Xytex Cryo International Ltd., Merck Group, Cook Group Incorporated, CooperSurgical Inc., Instituto Bernabeu, INVO Bioscience Inc., Cooper Companies Inc., Virtus Health Ltd., CryoChoice LLC, Millendo Therapeutics Inc., FUJIFILM Irvine Scientific Inc., LABOTECT GMBH, Fertility Focus Limited, Olympus Corporation, Irvine Scientific sales Company Inc., Ferring Pharmaceuticals Inc., Prelude Fertility Inc., Boston IVF, RMA Fertility Clinics, Shady Grove Fertility, CCRM Management Company LLC, IVIRMA Global, CARE Fertility

Which are the Top Profitable Regional Markets for the Fertility Treatments Industry?
North America was the largest region in the fertility treatment market in 2024. Western Europe was the second largest region in the fertility treatment market. The regions covered in the fertility treatments market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2811

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.